ECOR Stock Forecast: electroCore, Inc. Price Predictions for 2026-2027
The median 12-month analyst price target for electroCore, Inc. is $18. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 75 of 100 as at 21 Nov 2026 — inside the top quartile.
One number for the whole business
Consensus tells you what everyone already believes. The model scores electroCore, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (89): Sales and profits are climbing, and climbing faster than before.
Volatility (18): The share price moves around a lot.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
ECOR stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on ECOR, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Of the 20 most recent actions, 1 moved their price target up and 3 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 26 Jan 2026 | HC Wainwright & Co. | Maintains | Buy | $25 → $18 |
| 13 Mar 2025 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Mar 2025 | Ladenburg Thalmann | Maintains | Buy | — |
| 18 Dec 2024 | HC Wainwright & Co. | Maintains | Buy | — |
| 14 Mar 2024 | HC Wainwright & Co. | Reiterates | Buy | — |
| 22 Jan 2024 | HC Wainwright & Co. | Maintains | Buy | — |
| 9 Nov 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 10 Aug 2023 | HC Wainwright & Co. | Reiterates | Buy | — |
| 4 May 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 18 Apr 2023 | CG Capital | Reiterates | Outperform | — |
| 18 Apr 2023 | HC Wainwright & Co. | Maintains | Buy | — |
| 9 Mar 2023 | HC Wainwright & Co. | Reiterates | Buy | — |
| 13 Jan 2023 | Brookline Capital | Initiates | Buy | $1.25 |
| 19 Jan 2022 | HC Wainwright & Co. | Maintains | Buy | $3.00 → $2.75 |
| 27 July 2021 | Ladenburg Thalmann | Initiates | Buy | — |
| 23 Oct 2020 | Brookline Capital | Initiates | Buy | — |
| 30 Sept 2020 | Maxim Group | Initiates | Buy | — |
| 14 Aug 2020 | BTIG | Upgrade | Buy | — |
| 14 Aug 2020 | HC Wainwright & Co. | Maintains | Buy | $2.50 → $3.00 |
| 24 Mar 2020 | Cantor Fitzgerald | Maintains | Neutral | $4.00 → $2.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ECOR.
This page is one stock. Monday covers all of them.
ECOR appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
ECOR vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, electroCore, Inc. returned −3.7% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
ECOR analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- —
- Price / sales
- 1.2×
- Price / book
- —
- EV / EBITDA
- —
Cheaper than 61% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 86.5%
- Operating margin
- −33.1%
- Net margin
- —
Higher than 95% of US stocks
Higher than 20% of US stocks
- Return on equity
- —
- Return on assets
- −40.7%
- Dividend yield
- —
Higher than 10% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
electroCore, Inc. has a market value of $44.7M and an enterprise value of $46.9M.
Revenue in the twelve months to 30 June 2026: $37.0M. The latest quarter grew 28.0% year on year.
Net income over the same four quarters: −$14.8M, a −40.0% net margin.
Free cash flow in the twelve months to 30 June 2026: −$9.7M.
electroCore, Inc. employs 83 people — $445K of revenue per employee.
Data provided by Twelve Data
ECOR and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at ECOR’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own electroCore, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about ECOR
What is the ECOR stock price forecast for 2026-2027?
The median 12-month analyst price target for electroCore, Inc. is $18, with estimates ranging from $12 to $26. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Is ECOR stock a buy right now?
Of the 5 analysts covering electroCore, Inc., 5 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks electroCore, Inc. 75 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.
How does Ticker Nerd's model rank ECOR?
As at 21 Nov 2026, electroCore, Inc. ranks 75 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (89 of 100).
Will ECOR stock go up?
No one can know that. What the data says: the median 12-month target from 5 analysts is $18, and Ticker Nerd's factor model ranks electroCore, Inc. 75 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
What is the ECOR stock forecast for 2030?
No analyst covering electroCore, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ECOR are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $12 to $26 over the next 12 months.
How has ECOR stock performed over the past year?
electroCore, Inc. returned -3.7% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does electroCore, Inc. do?
electroCore, Inc. is a commercial-stage bioelectronic medicine company that develops non-invasive vagus nerve stimulation (nVNS) products for healthcare and wellness use. Its core offerings include gammaCore, a prescription handheld device used for primary headache conditions such as migraine and cluster headache, as well as Quell Fibromyalgia for chronic pain management.
About electroCore, Inc.
electroCore, Inc. is a commercial-stage bioelectronic medicine company that develops non-invasive vagus nerve stimulation (nVNS) products for healthcare and wellness use. Its core offerings include gammaCore, a prescription handheld device used for primary headache conditions such as migraine and cluster headache, as well as Quell Fibromyalgia for chronic pain management. The company also markets Truvaga and TAC-STIM, consumer-focused nVNS products designed to support general wellness and human performance. electroCore’s technology platform is built around non-invasive neuromodulation, with products intended for both clinical and personal use across the United States, the United Kingdom, and international markets. Headquartered in Rockaway, New Jersey, electroCore serves a growing role in the medical device and bioelectronic therapy sectors by offering portable, non-surgical alternatives that address pain, wellness, and performance-related needs.
CEO Mr. Joshua S. Lev · 83 employees · United States · https://www.electrocore.com